Book contents
- Progressive Brain Disorders in Childhood
- Progressive Brain Disorders in Childhood
- Copyright page
- Dedication
- Dedication
- Contents
- Preface
- Section 1 Introduction
- Section 2 Rise and Decline of the Child
- Section 3 Mechanisms of Neurological Loss of Function
- Section 4 Neurodegenerative and Other Progressive Disorders in Childhood
- Progressive in Utero Disorders
- Newborn Disorders
- Disorders of Infancy
- Childhood Disorders
- Adolescent Disorders
- Section 5 Regression in Other Neurological and Psychiatric Disorders
- Section 6 Induced Regression
- Index
- References
Adolescent Disorders
from Section 4 - Neurodegenerative and Other Progressive Disorders in Childhood
Published online by Cambridge University Press: 28 April 2017
Book contents
- Progressive Brain Disorders in Childhood
- Progressive Brain Disorders in Childhood
- Copyright page
- Dedication
- Dedication
- Contents
- Preface
- Section 1 Introduction
- Section 2 Rise and Decline of the Child
- Section 3 Mechanisms of Neurological Loss of Function
- Section 4 Neurodegenerative and Other Progressive Disorders in Childhood
- Progressive in Utero Disorders
- Newborn Disorders
- Disorders of Infancy
- Childhood Disorders
- Adolescent Disorders
- Section 5 Regression in Other Neurological and Psychiatric Disorders
- Section 6 Induced Regression
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Progressive Brain Disorders in Childhood , pp. 374Publisher: Cambridge University PressPrint publication year: 2017
References
Bibliography
Patell, R., Dosi, R., Joshi, H.K., et al. (2014). Atypical neuroimaging in Wilson’s disease. BMJ Case Rep. 2014. pii:bcr2013200100.CrossRefGoogle Scholar
Bibliography
Dusek, P., Schneider, S.A., Aaseth, J. (2016). Iron chelation in the treatment of neurodegenerative diseases. J Trace Elem Med Biol. pii:S0946–672X(16)30047–5.Google Scholar
Meyer, E., Kurian, M.A., Hayflick, S.J. (2015). Neurodegeneration with brain iron accumulation: Genetic diversity and pathophysiological mechanisms. Annu Rev Genomics Hum Genet. 16:257–79.CrossRefGoogle ScholarPubMed
Schulte, E.C., Claussen, M.C., Jochim, A., et al. (2013). Mitochondrial membrane protein associated neurodegeneration: A novel variant of neurodegeneration with brain iron accumulation. Mov Disord. 28(2):224–7.CrossRefGoogle ScholarPubMed
Bibliography
Kuhn, J., Bewermeyer, H., Miyajima, H., et al. (2007). Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate. Brain Dev. 29(7):450–3.CrossRefGoogle ScholarPubMed
Meyer, E., Kurian, M.A., Hayflick, S.J. (2015). Neurodegeneration with brain iron accumulation: Genetic diversity and pathophysiological mechanisms. Annu Rev Genomics Hum Genet. 16:257–79.CrossRefGoogle ScholarPubMed
Bibliography
Jain, R.S., Sannegowda, R.B., Agrawal, A., et al. (2013). “Hot cross bun” sign in a case of cerebrotendinous xanthomatosis: A rare neuroimaging observation. BMJ Case Rep. 2013. pii:bcr2012006641.Google Scholar
Nie, S., Chen, G., Cao, X., et al. (2014). Cerebrotendinous xanthomatosis: A comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 9:179.CrossRefGoogle ScholarPubMed
Bibliography
Monrad, P., Renaud, D.L. (2013). Typical clinical findings should prompt investigation for juvenile Huntington disease. Pediatr Neurol. 48(4):333–4.CrossRefGoogle ScholarPubMed
Roos, R.A. (2010). Huntington’s disease: A clinical review. Orphanet J Rare Dis. 5:40.CrossRefGoogle ScholarPubMed
Bibliography
Chan, K.Y., Ching, C.K., Mak, C.M., et al. (2009). Hereditary spastic paraplegia: Identification of an SPG3A gene mutation in a Chinese family. Hong Kong Med J. 15(4):304–7.Google Scholar
de Souza, P.V., de Rezende Pinto, W.B., de Rezende Batistella, G.N., et al. (2016) Hereditary spastic paraplegia: Clinical and genetic hallmarks. Cerebellum. Jun 7.CrossRefGoogle Scholar
Bibliography
Andrade, D.M., Paton, T., Turnbull, J., et al. (2012). Mutation of the CLN6 gene in teenage-onset progressive myoclonus epilepsy. Pediatr Neurol. 47(3):205–8.CrossRefGoogle ScholarPubMed
Arsov, T., Smith, K.R., Damiano, J., et al. (2011). Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6. Am J Hum Genet. 88(5):566–73.CrossRefGoogle ScholarPubMed
Bibliography
Belzil, V.V., Langlais, J.S., Daoud, H., et al. (2012). Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosis. Arch Neurol. 69(5):653–6.Google Scholar
Finsterer, J., Burgunder, J.M. (2014). Recent progress in the genetics of motor neuron disease. Eur J Med Genet. 57(2–3):103–12.CrossRefGoogle ScholarPubMed
Sharma, A., Lyashchenko, A.K., L. L., et al. (2016). ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat Commun. 7:10465.CrossRefGoogle ScholarPubMed
Bibliography
Kalia, L.V., Lang, A.E. (2016). Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD. Nat Rev Neurol. 12(2):65–6.CrossRefGoogle ScholarPubMed
Malakouti-Nejad, M., Shahidi, G.A., Rohani, M., et al. (2014). Identification of p.Gln858* in ATP13A2 in two EOPD patients and presentation of their clinical features. Neurosci Lett. 577:106–11.CrossRefGoogle ScholarPubMed